Drug intelligence / Profile preview

Fc-BCAM

Development stage
Preclinical
Lead developer
University of Helsinki
Modality
Fc-Fusion Proteins → Carrier/Scaffold Proteins → Recombinant Proteins and Enzymes
Administration
Intravenous, Intraperitoneal
01

Overview

Fc-BCAM is a recombinant fusion protein consisting of the extracellular domain of the Basal Cell Adhesion Molecule (BCAM) fused to the Fc region of an immunoglobulin (typically IgG1). BCAM, also known as the Lutheran blood group glycoprotein (Lu), is a cell surface receptor that specifically binds to the laminin alpha-5 (LAMA5) chain, a key component of the extracellular matrix in basement membranes. In various malignancies, particularly ovarian cancer, the interaction between membrane-bound BCAM and LAMA5 facilitates tumor cell adhesion, migration, and the formation of spheroids, which are critical for peritoneal metastatic spread. Fc-BCAM acts as a decoy receptor or 'trap' by competitively binding to LAMA5, thereby preventing the interaction between endogenous BCAM on cancer cells and the basement membrane. This inhibition disrupts the mechanical and signaling pathways required for metastasis and tumor progression.

Other names
BCAM-Fc fusion proteinRecombinant Human BCAM Fc ChimeraLutheran-Fc fusion proteinsBCAM-Fc

Beyond the preview

Go deeper on Fc-BCAM.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Fc-BCAM.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call